Siemens to feature IT quality measuresWood heads image analysis firm
Siemens to feature IT quality measures
Siemens will demonstrate on Oct. 4 how its Soarian Quality Measures product saves time and improves accuracy associated with chart abstraction, as well as prepares users for Medicare’s upcoming plans to increase the number of core quality measures. The presentation will be part of an educational breakout session at the American Health Information Management Association Convention and Exhibit in Grapevine, TX. The company will also feature Soarian Quality Measures in its booth among other information technology tools that offer plan-of-care functionality, enterprise document management, and state-of-the-art data mining and reporting.
Wood heads image analysis firm
Susan A. Wood, Ph.D., is the new president and CEO of VIDA Diagnostics, a developer of quantitative imaging software used in clinical research to analyze pulmonary diseases, including asthma and lung cancer, and chronic obstructive pulmonary disease. Wood succeeds John Garber, who helped build VIDA from an academic concept. Wood will focus on the continued development and commercialization of the company's FDA-cleared pulmonary applications, while transitioning quantitative pulmonary imaging into routine clinical practice. Wood joined VIDA's board last year. Previously she served as executive vice president of marketing and technology at Vital Images and led marketing and new product development at R2 Technology, now part of Hologic.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.